Literature DB >> 12865824

Azathioprine-induced fatal myelosuppression in a renal-transplant recipient who carried heterozygous TPMT*1/*3C.

Wichittra Tassaneeyakul, Somrudee Srimarthpirom, Sirirat Reungjui, Kanchana Chansung, Amornrat Romphruk, Wongwiwat Tassaneeyakul.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12865824     DOI： 10.1097/01.TP.0000070521.22024.F1

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  4 in total

1.  Distribution of TPMT risk alleles for thiopurine [correction of thioupurine] toxicity in the Israeli population.

Authors:  Edna Efrati; Lior Adler; Norberto Krivoy; Eli Sprecher
Journal:  Eur J Clin Pharmacol       Date:  2008-12-02       Impact factor: 2.953

2.  Thiopurine S-methyltransferase genetic polymorphism in the Thai population.

Authors:  Somrudee Srimartpirom; Wongwiwat Tassaneeyakul; Veerapol Kukongviriyapan; Wichittra Tassaneeyakul
Journal:  Br J Clin Pharmacol       Date:  2004-07       Impact factor: 4.335

3.  Thiopurine methyltransferase predicts the extent of cytotoxicty and DNA damage in astroglial cells after thioguanine exposure.

Authors:  Amira Hosni-Ahmed; Joseph D Barnes; Jim Wan; Terreia S Jones
Journal:  PLoS One       Date:  2011-12-21       Impact factor: 3.240

Review 4.  Chemotherapy, targeted therapy and immunotherapy: Which drugs can be safely used in the solid organ transplant recipients?

Authors:  Umberto Maggiore; Alessandra Palmisano; Sebastiano Buti; Giulia Claire Giudice; Dario Cattaneo; Nicola Giuliani; Enrico Fiaccadori; Ilaria Gandolfini; Paolo Cravedi
Journal:  Transpl Int       Date:  2021-10-28       Impact factor: 3.842
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.